Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127174031 | 12717403 | 1 | I | 20160829 | 20160906 | 20160906 | EXP | US-JNJFOC-20160827682 | JANSSEN | HOU M, LIU X, WHELER J, NAING A, HONG D, COLEMAN R, ET AL. TARGETED PI3K/AKT/MTOR THERAPY FOR METASTATIC CARCINOMAS OF THE CERVIX: A PHASE I CLINICAL EXPERIENCE. ONCOTARGET 2014;5 (22):11168-11179. | 0.00 | A | F | Y | 0.00000 | 20160906 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127174031 | 12717403 | 1 | PS | DOXORUBICIN HYDROCHLORIDE. | DOXORUBICIN HYDROCHLORIDE | 1 | Unknown | U | U | 50718 | LIPOSOME INJECTION | ||||||||
| 127174031 | 12717403 | 2 | SS | BEVACIZUMAB | BEVACIZUMAB | 1 | Unknown | U | 0 | UNSPECIFIED | |||||||||
| 127174031 | 12717403 | 3 | SS | TEMSIROLIMUS | TEMSIROLIMUS | 1 | Unknown | U | 0 | UNSPECIFIED |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127174031 | 12717403 | 1 | Cervix carcinoma |
| 127174031 | 12717403 | 2 | Cervix carcinoma |
| 127174031 | 12717403 | 3 | Cervix carcinoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127174031 | 12717403 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127174031 | 12717403 | Bacterial infection | |
| 127174031 | 12717403 | Fatigue | |
| 127174031 | 12717403 | Hypokalaemia | |
| 127174031 | 12717403 | Hypomagnesaemia | |
| 127174031 | 12717403 | Hyponatraemia | |
| 127174031 | 12717403 | Hypophosphataemia | |
| 127174031 | 12717403 | Intestinal perforation | |
| 127174031 | 12717403 | Mucosal inflammation | |
| 127174031 | 12717403 | Neutropenia | |
| 127174031 | 12717403 | Off label use | |
| 127174031 | 12717403 | Product use issue | |
| 127174031 | 12717403 | Thrombocytopenia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |